RBR-9wkw73j招募中未知
Randomized clinical study of the use of intravitreal injection of Bevacizumab inprimary open-angle glaucoma.
nião Metropolitana de Educação e Cultura0 个研究点开始时间: 2021年5月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 40Y 至 0（—）
入选标准
- •The inclusion criteria will be: Primary Open Angle patients over 40 years of age, with uncontrolled Intraocular pressure (IOP) on maximum tolerated medical therapy, requiring trabeculectomy. Indications for trabeculectomy will include eyes where IOP measurements associated with a high probability of glaucoma progression or eyes where a deterioration of the visual field or the optic disk compatible with progressive glaucomatous damage was documented by the examining physician.
排除标准
- •Patients will be excluded if known to have an allergic reaction either to MMC or BZM, had undergone previous intraocular surgery (except uneventful cataract surgery); were diagnosed with normal tension glaucoma, angle closure glaucoma or secondary glaucomas; had prior history of ocular infection, uveitis or ocular trauma; were pregnant or breast-feeding women; had a history of uncontrolled diabetes and/or systemic hypertension or any other systemic condition that could be influenced by BZM injections
研究者
相似试验
进行中（未招募）
不适用
A Pilot study investigating the use of Intravitreal Triamcinolone prior to macular laser for Clinically Significant Diabetic Macular Oedema - CSMO and triamcinoloneMacular oedema affects 29% of diabetic patients and is the main cause of visual impairment. Previous studies show that diffuse macular oedema carries a particularly poor prognosis despite laser photocoagulation.EUCTR2004-005043-97-GBSt Mary's NHS Trust50
进行中（未招募）
1 期
A Pilot Study Evaluating the Effect of Intravitreal Fluocinolone Acetonide (0.19mg) in Patients with Retinitis Pigmentosa.Retinitis Pigmetosa.MedDRA version: 19.0 Level: PT Classification code 10038914 Term: Retinitis pigmentosa System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-002523-28-GBMoorfields Eye Hospital1
已完成
不适用
Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000005691Department of Ophthalmology, Shiga University of Medical Science40
已完成
不适用
Evaluation of the efficacy and safety of intravitreal bimonthly injection of aflibercept for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000010312Department of Ophthalmology, Shiga University of Medical Science40
已完成
3 期
a clinical trial to find the most appropriate maintenance fluid in children with central nervous system infectioCTRI/2012/05/002637Kalawati Saran Chiuldrens Hospital90